Deadline: 05-Dec-2025
The Technology Innovation Agency (TIA) of South Africa and BioCubaFarma of Cuba have jointly announced a call for Expressions of Interest to promote biotechnology collaboration, technology transfer, joint development, and commercialization between entities in South Africa and Cuba, aiming to leverage innovative biotech products to address health challenges and enhance global market reach.
Focus Areas: The call focuses on technology transfer, joint development, and joint ventures in biotechnology products; the development aims to combat neurodegenerative diseases such as Parkinson’s disease, Multiple Sclerosis, Dementia, lung cancer, and Alzheimer’s Disease through a bilateral framework agreement between South Africa and Cuba.
This initiative between TIA and BioCubaFarma represents a structured partnership established under a Framework Agreement signed in July 2025 to harness and internationalize promising biotechnology innovations from both countries. The collaboration seeks to provide both financial and non-financial support, ensuring transparency of Cuban technologies available for transfer and joint commercialization efforts. Entities eligible to participate include research institutions, universities, or biotech companies with capabilities in biotechnology, clinical research, diagnostics, and therapeutic development. These organizations will have the opportunity to co-develop projects and engage in technology transfer initiatives. Projects proposed by BioCubaFarma encompass a range of therapeutic areas and vaccines, including but not limited to treatments targeting Parkinson’s Disease, Multiple Sclerosis, Alzheimer’s Disease, various solid tumors, chronic obstructive pulmonary diseases, lung cancer, and dementia. The call specifically highlights products at different Technology Readiness Levels (TRL) available for partnership, with Cuban institutions such as the Cuban Center for Neuroscience, Center for Genetic Engineering and Biotechnology, Center for Molecular Immunology, and AICA pharmaceutical lab being key partners. Applicants are required to submit a cover letter, company profile, project proposal, supporting documentation such as case studies, and a completed questionnaire, demonstrating their capacity for collaborative research and product development.
For more information, visit TIA.
